Novo Integrated Sciences announced the signing of a Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India. This partnership initiates a strategic initiative to introduce new products and state-of-the-art healthcare technologies to the Indian market, with plans to extend healthcare related products to the North American market, Novo Integrated said in a statement. The 3-year agreement allows for the potential for extension through mutual agreement. Initially, PCHPL and Novo are expected to launch products related to the central nervous system, gastro, and protein supplements.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NVOS:
- Novo Integrated Sciences receives court approval for Ophir Collection agreement
- Novo Integrated regains compliance with Nasdaq minimum bid price requirement
- Reverse Stock Split Prompts Nightmare Plunge for Novo Integrated Sciences (NASDAQ:NVOS)
- Novo Integrated Sciences announces 1-for-10 reverse stock split
- Novo Integrated Sciences board approves $5M stock repurchase program
